Seed VC · USA

Avalon Bioventures

Active

What they invest in

Focused on first-in-class innovations to transform patient care, investing in innovative science at the earliest stages and seeking white space opportunities that are often too early for other investors, with a hands-on approach from company formation to successful exits.

Who they back

DeepTechHealthtechBiotechbiomedical venture firm spun out from Avalon VenturesSeedSeries A

Business models

biotech_therapeutics

Customer segments

Researchers, Patients

Geography

US

Recent investments

  • Janux Therapeutics
  • Synthorx, Inc.
  • Sitari, Inc.

+ 2 more deals. Score your deck to see the full investment history.

The people who write checks

1 partners on file at Avalon Bioventures, with the firm's email pattern for cold outreach. Score your deck (free, 30 seconds) to unlock direct contact for this firm and 47,000+ others.

We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

Avalon Bioventures writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Avalon Bioventures alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Based in
United States
Last known deal
Dec 2022
Portfolio last checked
Oct 6, 2026
Website
www.avalonbioventures.com ↗

Other firms investing in DeepTech

See all investors

Is Avalon Bioventures the right fit for your deck?

Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Avalon Bioventures is one of them, and we'll tell you exactly where they sit in your top 100.